北京大学学报(医学版) ›› 2018, Vol. 50 ›› Issue (2): 318-325. doi: 10.3969/j.issn.1671-167X.2018.02.019

• 论著 • 上一篇    下一篇

拓扑异构酶抑制剂通过ATM/ATR和NF-κB途径上调乳腺癌细胞MICA/B 的表达

朱燕1,石永进2,赵玉亮1,朱平2△   

  1. (北京大学第一医院 1. 肿瘤化疗科, 2.血液科, 北京100034)
  • 出版日期:2018-04-18 发布日期:2018-04-18
  • 通讯作者: 朱平 E-mail:zhuping@bjmu.edu.cn
  • 基金资助:
    国家自然科学基金 (81370612)和国家自然科学青年基金(81102211)资助

Topoisomerase inhibitor upregulates MICA/B expression in breast cancer cells through ATM/ATR and NF-κB pathway

ZHU Yan1,SHI Yong-jin2,ZHAO Yu-liang1, ZHU Ping2△   

  1. (1. Department of Oncology, 2. Department of Hematology,Peking University First Hospital,Beijing 100034, China)
  • Online:2018-04-18 Published:2018-04-18
  • Contact: ZHU Ping E-mail:zhuping@bjmu.edu.cn
  • Supported by:
    Supported by the National Natural Science Foundation of China (81370612) and the National Natural Science Yong Scholar Foundation of China (81102211)

摘要: 目的:分析常用化疗药物对免疫识别乳腺癌细胞重要的靶标主要组织相容性复合体Ⅰ类相关分子A和B(major histocompatibility complex class Ⅰ-related chain A and B,MICA/B)的影响,探讨其调节MICA/B表达的分子机制。方法:用荧光定量RT-PCR法检测化疗药物对乳腺癌细胞MICA和MICB mRNA表达的影响,流式细胞术检测化疗药物对MICA/B表面蛋白表达的作用。加入咖啡因抑制毛细血管扩张性共济失调突变和Rad3相关激酶(ataxia telangiectasia mutated and Rad3related kinase,ATM/ATR),加入吡咯烷二硫氨基甲酸酯(pynolidine dithiocarbamate,PDTC)抑制核因子κB(nuclear factor κB,NF-κB),观察其是否能够抑制化疗药物中拓扑异构酶抑制剂对乳腺癌细胞MICA和MICB mRNA及蛋白的表达。凝胶阻滞实验(electrophoretic mobility shift assay,EMSA)检测药物是否影响乳腺癌细胞NF-κB与MICA/B启动子区的结合。结果:三种拓扑异构酶抑制剂足叶乙甙、拓扑替康和阿霉素可使乳腺癌MCF-7细胞的MICA和MICB mRNA水平升高。足叶乙甙在浓度为5、20、100 μmol/L时,与不加药处理组相比,MICA mRNA水平分别升高到(1.68±0.17)、 (2.54±0.25)、 (3.42±0.15)倍(P<0.05);MICB mRNA水平分别升高到(1.82±0.24)、(1.56±0.05)、(5.84±0.57)倍(P<0.05)。拓扑替康和阿霉素在特定浓度时也使MCF-7的MICA和MICB mRNA水平显著升高(P<0.05)。拓扑异构酶Ⅱ抑制剂足叶乙甙和拓扑替康处理另一乳腺癌细胞系SK-BR-3后,MICB mRNA的表达也轻度升高(P<0.05)。足叶乙甙和拓扑替康还增加MCF-7细胞表面MICA/B蛋白的表达(P<0.05),且存活和凋亡细胞MICA/B蛋白的表达均增高。用不同浓度的咖啡因处理足叶乙甙损伤的乳腺癌细胞,MICA/B mRNA和蛋白表达均显著降低,当咖啡因浓度为1、 5、 10 mmol/L时,MICA mRNA相对表达水平由不用咖啡因处理组的(3.75±0.25)倍分别降为(0.89±0.05)、(0.81±0.02)、(0.48±0.04)倍(P<0.001),MICB mRNA由(6.85±0.35)倍降为(1.36±0.13)、(0.76±0.06)、(0.56±0.03)倍(P<0.05),MICA/B蛋白表达由(3.42±0.05)倍降为(1.32±0.03)、(1.21±0.06)、(1.14±0.03)倍(P<0.001),表明足叶乙甙对MICA/B的上调作用能够被ATM/ATR抑制剂所抑制。同样,加入不同浓度的NF-κB的强抑制剂PDTC(10、50、100 μmol/L),MICA/B mRNA和蛋白的表达均明显受到抑制(P<0.05),提示NF-κB也参与这一过程。EMSA实验显示,MCF-7细胞用足叶乙甙处理后,NF-κB与MICA/B基因启动子区的结合活性增强。结论:拓扑异构酶抑制剂诱导并上调乳腺癌细胞MICA和MICB mRNA及表面蛋白的表达,表明化疗药物有可能增强免疫系统对乳腺癌的识别和杀伤,ATM/ATR和NF-κB途径参与了这一过程。

关键词: 拓扑异构酶抑制剂, MHCⅠ类链相关分子A/B, 毛细血管扩张性共济失调突变蛋白, 毛细血管扩张性共济失调Rad3相关激酶, NF -&kappa, B, 乳腺肿瘤

Abstract: Objective: To investigate the effects of chemotherapeutic agents widely used in clinical practice on major histocompatibility complex class Ⅰ-related chain A and B (MICA/B) expression in breast cancer cells, and to explore the molecular mechanisms involved. Methods: We examined MICA/B mRNA and surface protein expressions in breast cancer cells treated with chemotherapeutic agents by real-time RT-PCR and flow cytometry respectively. The blocking effects of ataxia telangiectasia mutated and Rad3-related kinase (ATM/ATR) inhibitor caffeine and nuclear factor κB (NF-κB) inhibitor pyno-lidine dithiocarbamate (PDTC) on etoposide-upregulated MICA/B mRNA and surface protein expressions were investigated. Electrophoretic mobility shift assay (EMSA) was taken to investigate whether etoposide enhanced the binding of NF-κB to MICA/B gene promoter. Results: Three topoisomerase inhibitors etoposide, camptothecin and doxorubicine upregulated MICA and MICB mRNA expressions in breast cancer cell MCF-7. Comparing to no-drug-treated cells, MICA mRNA levels increased to (1.68±0.17), (2.54±0.25) and (3.42±0.15) fold, and levels of MICB mRNA increased to (1.82±0.24), (1.56±0.05) and (5.84±0.57) fold respectively in cancer cells treated by etoposide at the concentrations of 5, 20 and 100 μmol/L (P<0.05). MICA and MICB mRNA levels also increased significantly when MCF-7 cells were incubated with camptothecin or doxorubicine at the specific concentrations (P<0.05). MICB mRNA expression also increased slightly in another breast cancer cell SK-BR-3 treated by topoisomerase Ⅱ inhibitors etoposide and camptothecin (P<0.05). Furthermore, etoposide and camptothecin upregulated MICA/B surface protein expression in MCF-7 cells (P<0.05), and the upregulation was found in both living and apoptotic cells. Our study showed that etoposide induced-MICA/B expression in MCF-7 was inhibited by caffeine at different concentrations. When cancer cells were treated by caffeine with 1, 5 and 10 mmol/L, MICA mRNA levels decreased from (3.75±0.25) to (0.89±0.05), (0.81±0.02) and (0.48±0.04) fold respectively (P<0.001), and MICB mRNA levels decreased from (6.85±0.35) to (1.36±0.13), (0.76±0.06) and (0.56±0.03) fold (P<0.05), while MICA/B protein levels decreased from (3.42±0.05) to (1.32±0.03), (1.21±0.06) and (1.14±0.03) fold (P<0.001), indicating that etoposide-induced MICA/B expression was inhibited by ATM/ATR inhibitor. Similarly, NF-κB inhibitor PDTC also inhibited MICA/B mRNA and protein expressions induced by etoposide significantly when MCF-7 cells were incubated with PDTC at the concentrations of 10, 50 and 100 μmol/L (P<0.05), indicating that NF-κB was also involved in this process. EMSA showed that the binding of NF-κB to MICA/B promoter enhanced in MCF-7 cells after etoposide treatment. Conclusion: Topoisomerase inhibitor increased MICA/B mRNA and protein expressions in breast cancer cells, indicating that chemotherapeutic agents might increase the recognizing and killing ability of immunocytes to breast cancer cells. ATM/ATR and NF-κB pathways might be involved in it.

Key words: Topoisomerase inhibitors, MHC class I-related chain A/B, Ataxia telangiectasia mutated proteins, Ataxia telangiectasia and Rad3-related kinase, NF-kappa B, Breast neoplasms

中图分类号: 

  •  
[1] 朱小玲,李文静,王宪娥,宋文莉,徐莉,张立,冯向辉,路瑞芳,释栋,孟焕新. 细胞色素B-245α链及胆固醇酯转运蛋白基因多态性与广泛型侵袭性牙周炎易感性的关系[J]. 北京大学学报(医学版), 2022, 54(1): 18-22.
[2] 范莹莹,刘云,曹烨,谢秋菲. 海马参与雌激素加重咬合干扰致去卵巢大鼠慢性咬肌痛敏[J]. 北京大学学报(医学版), 2022, 54(1): 40-47.
[3] 杜文瑜,杨静文,姜婷. 甲磺酸去铁胺促进大鼠颅骨临界骨缺损血管化骨再生的早期连续观察[J]. 北京大学学报(医学版), 2021, 53(6): 1171-1177.
[4] 庞泳,张沙,杨华,周柔丽. LAPTM4B-35蛋白作为肝癌血清学诊断新标志物的探讨[J]. 北京大学学报(医学版), 2021, 53(4): 710-715.
[5] 马向波,张学武,贾汝琳,高颖,刘洪江,刘玉芳,李英妮. 外周血淋巴细胞亚群检测在系统性硬化症治疗中的应用[J]. 北京大学学报(医学版), 2021, 53(4): 721-727.
[6] 冯菁楠,高乐,孙一鑫,杨继春,邓思危,孙凤,詹思延. Xpert®MTB/RIF对我国人群活动性肺结核和利福平耐药肺结核诊断准确性的meta分析[J]. 北京大学学报(医学版), 2021, 53(2): 320-326.
[7] 赵世明,杨铁军,许春苗,郭孝峰,马永康,陈学军,李祥,何朝宏. 3.0T磁共振成像在接受过经尿道膀胱肿瘤切除术膀胱癌中诊断肌层浸润的应用[J]. 北京大学学报(医学版), 2020, 52(4): 701-704.
[8] 轩艳,蔡宇,王啸轩,石巧,邱立新,栾庆先. 牙龈卟啉单胞菌感染对载脂蛋白e基因敲除小鼠动脉粥样硬化的影响[J]. 北京大学学报(医学版), 2020, 52(4): 743-749.
[9] 陈章健,韩硕,郑湃,周淑佩,贾光. 纳米二氧化钛与葡萄糖亚慢性联合经口暴露对幼年大鼠血清叶酸和维生素B12水平的影响[J]. 北京大学学报(医学版), 2020, 52(3): 451-456.
[10] 赵磊,张洪宪,侯小飞,刘磊,陆敏,韩永,马潞林. 来氟米特联合羟苯磺酸钙治疗肾移植术后BK病毒相关性肾病[J]. 北京大学学报(医学版), 2020, 52(2): 385-389.
[11] 马博,田志华,曲莉,刘月香,张宏,丁慧荣. 索拉菲尼诱导的肝癌耐药细胞株的建立及基因表达分析[J]. 北京大学学报(医学版), 2020, 52(2): 207-213.
[12] 宋国红,李惠平,邸立军,严颖,姜晗昉,徐玲,万冬桂,李瑛,王墨培,肖宇,张如艳,冉然,王环. 真实世界吡咯替尼治疗HER2阳性转移性乳腺癌的疗效及安全性[J]. 北京大学学报(医学版), 2020, 52(2): 254-260.
[13] 白向松,吕珑薇,周永胜. Tribbles同源蛋白3抑制人脂肪间充质干细胞成脂向分化[J]. 北京大学学报(医学版), 2020, 52(1): 1-9.
[14] 田艳,朱军. p53 rs1625895基因多态性与弥漫大B细胞淋巴瘤预后相关性分析[J]. 北京大学学报(医学版), 2019, 51(5): 791-796.
[15] 朱学华,杨明钰,夏海缀,何为,张智荧,刘余庆,肖春雷,马潞林,卢剑. 机器学习模型在预测肾结石输尿管软镜碎石术后早期结石清除率中的应用[J]. 北京大学学报(医学版), 2019, 51(4): 653-659.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 田增民, 陈涛, Nanbert ZHONG, 李志超, 尹丰, 刘爽. 神经干细胞移植治疗遗传性小脑萎缩的临床研究(英文稿)[J]. 北京大学学报(医学版), 2009, 41(4): 456 -458 .
[2] 郭岩, 谢铮. 用一代人时间弥合差距——健康社会决定因素理论及其国际经验[J]. 北京大学学报(医学版), 2009, 41(2): 125 -128 .
[3] 成刚, 钱振华, 胡军. 艾滋病项目自愿咨询检测的技术效率分析[J]. 北京大学学报(医学版), 2009, 41(2): 135 -140 .
[4] 卢恬, 朱晓辉, 柳世庆, 郑杰, 邱晓彦. 白细胞介素2促进宫颈癌细胞系HeLaS3免疫球蛋白G的表达[J]. 北京大学学报(医学版), 2009, 41(2): 158 -161 .
[5] 袁惠燕, 张苑, 范田园. 离子交换型栓塞微球及其载平阳霉素的制备与性质研究[J]. 北京大学学报(医学版), 2009, 41(2): 217 -220 .
[6] 徐莉, 孟焕新, 张立, 陈智滨, 冯向辉, 释栋. 侵袭性牙周炎患者血清中抗牙龈卟啉单胞菌的IgG抗体水平的研究[J]. 北京大学学报(医学版), 2009, 41(1): 52 -55 .
[7] 董稳, 刘瑞昌, 刘克英, 关明, 杨旭东. 氯诺昔康和舒芬太尼用于颌面外科术后自控静脉镇痛的比较[J]. 北京大学学报(医学版), 2009, 41(1): 109 -111 .
[8] 祁琨, 邓芙蓉, 郭新彪. 纳米二氧化钛颗粒对人肺成纤维细胞缝隙连接通讯的影响[J]. 北京大学学报(医学版), 2009, 41(3): 297 -301 .
[9] Jian-wei GU, Emily YOUNG, Zhi-jun PAN, Kevan B. TUCKER, Megan SHPARAGO, Min HUANG, Amelia Purser BAILEY. SD大鼠长期高盐饮食可导致其高血压并改变肾细胞因子基因表达谱[J]. 北京大学学报(医学版), 2009, 41(5): 505 -515 .
[10] 李宏亮*, 安卫红*, 赵扬玉, 朱曦. 妊娠合并高脂血症性胰腺炎行血液净化治疗1例[J]. 北京大学学报(医学版), 2009, 41(5): 599 -601 .